Atulya Medipharma Private Limited

Atulya Medipharma Private Limited - paper in Indore, Madhya Pradesh, India. Directors, charges & compliance details.
CIN U21002MP2024PTC073205 Incorporated 11 October 2024 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company paper
Data last updated
Revenue · FY 2025
₹20.09 Lakh
Latest filing
Net loss · FY 2025
₹1.49 Lakh
Net margin -7.4%
EBITDA · FY 2025
-₹1.48 Lakh
EBITDA margin -7.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
2 yrs
Est. 2024
Directors on board
4
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Atulya Medipharma Private Limited

Data last updated:

Atulya Medipharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 11 October 2024.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U21002MP2024PTC073205.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Gaurav Yadav and Gautam Yadav.

Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.

As per the financials filed for FY 2025, the company reported a revenue of ₹20.09 Lakh. For the same year it recorded a net loss of ₹1.49 Lakh (net margin -7.4%) and EBITDA of -₹1.48 Lakh (EBITDA margin -7.4%).

Company Details of Atulya Medipharma Private Limited
CIN U21002MP2024PTC073205
Registration Number 073205
Incorporation Date 11 October 2024
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    H No 117 Aranya Sch No 78, Sla 1 Sec A Vijay Nagar, Indore, Madhya Pradesh, India – 452010
  • Industry
    Paper, Paper & Paper Products, Manufacturing
Comprehensive company report
Atulya Medipharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Atulya Medipharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Atulya Medipharma Private Limited in one report.

Financials from FY 2025 Directors & ownership Charges & compliance

Financials of Atulya Medipharma Private Limited FY 2025 filings available

Atulya Medipharma Private Limited reported revenue of ₹20.09 Lakh for FY 2025.

Revenue · FY 2025
₹20.09 Lakh
Net loss · FY 2025
₹1.49 Lakh margin -7.4%
EBITDA · FY 2025
-₹1.48 Lakh margin -7.4%

Financial Statement Summary of Atulya Medipharma Private Limited

MetricsFY 2024-25
Profit and Loss Statement
Revenue from Operations••••
Other Income••••
Total Revenue••••
Cost of Materials Consumed••••
Employee Benefit Expense••••
Finance Costs••••
Depreciation and Amortisation••••
Other Expenses••••
Total Expenses••••
EBITDA-₹1.48 Lakh
Profit Before Tax••••
Tax Expense••••
Net Profit (PAT)-₹1.49 Lakh
Balance Sheet
Share Capital••••
Reserves and Surplus••••
Net Worth (Total Equity)••••
Long-term Borrowings••••
Short-term Borrowings••••
Trade Payables••••
Total Liabilities••••
Fixed Assets••••
Investments••••
Inventories••••
Trade Receivables••••
Cash and Bank Balance••••
Total Assets••••

Financial Ratios of Atulya Medipharma Private Limited

MetricsFY 2024-25
Profitability
EBITDA Margin-7.4%
Net Profit Margin-7.4%
Return on Equity (ROE)••••
Return on Capital Employed (ROCE)••••
Return on Assets (ROA)••••
Liquidity and Debt
Current Ratio••••
Quick Ratio••••
Debt-to-Equity Ratio••••
Interest Coverage Ratio••••
Efficiency and Growth
Asset Turnover••••
Receivable Days••••
Payable Days••••
Inventory Days••••
Revenue Growth••••
Net Profit Growth••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Atulya Medipharma are in the company report.

Premium access

Financial statements from FY 2025

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Atulya Medipharma Private Limited

Atulya Medipharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Masscure Medicines Private Limited₹20.37 Lakh (FY 2025)••••••••-69.0%••••Ganpati Mandir, Kolhapur, Maharashtra, India
Suvinys Developers Private Limited₹20.27 Lakh (FY 2024)••••••••-98.0%••••New Delhi, Delhi, India
Mehta Formulations Private Limited₹20.26 Lakh (FY 2025)••••••••-9.0%••••Kolkata, West Bengal, India
Unizy Healthcare Private Limited₹20.21 Lakh (FY 2021)••••••••185.0%••••Bharuch, Gujarat, India
Sankarajyothi Ayurvedic and Herbals Private Limited₹20.2 Lakh (FY 2024)••••••••7.0%••••Adoor, Kerala, India
Atulya Medipharma Private Limited this company₹20.09 Lakh (FY 2025)••••••••••••Indore, Madhya Pradesh, India
Eira Life Sciences Private Limited₹20.06 Lakh (FY 2024)••••••••2.0%••••Chennai, Tamil Nadu, India
Aushi Immunosciences Private Limited₹20.01 Lakh (FY 2024)••••••••202.0%••••Kashipur, Uttarakhand, India
Nanotech Medical Solution Private Limited₹19.95 Lakh (FY 2019)••••••••-89.0%••••Patna, Bihar, India
Om Life Care Private Limited₹19.95 Lakh (FY 2019)••••••••-46.0%••••Jaipur, Rajasthan, India
Ayyan Life Sciences Private Limited₹19.84 Lakh (FY 2024)••••••••••••Hyderabad, Telangana, India

Peers are the five companies nearest above and the five nearest below Atulya Medipharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Board of Directors of Atulya Medipharma Private Limited

Atulya Medipharma has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Gaurav YadavDirector11 Oct 20242 Years 0 MonthsCurrent
Gautam YadavDirector11 Oct 20242 Years 0 MonthsCurrent
Sachin YadavDirector11 Oct 20242 Years 0 MonthsCurrent
Mohan Singh RajputDirector11 Oct 20242 Years 0 MonthsCurrent

Charges & Borrowings of Atulya Medipharma Private Limited

Atulya Medipharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Atulya Medipharma Private Limited

Employment history and EPFO contributions of people linked to Atulya Medipharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Atulya Medipharma Private Limited

Atulya Medipharma Private Limited has 4 board changes on record since 2024: 4 appointments. The latest: Gaurav Yadav was appointed as Director on 11 Oct 2024.

AGM
Atulya Medipharma Private Limited last Annual general meeting of members was held on 31 Dec 2025 as per latest MCA records.
Filing
Atulya Medipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Gaurav Yadav was appointed as Director.
Appointed
Gautam Yadav was appointed as Director.
Appointed
Mohan Singh Rajput was appointed as Director.
Appointed
Sachin Yadav was appointed as Director.
Incorporation
11 Oct 2024
Atulya Medipharma Private Limited was registered on 11 Oct 2024 with Roc Gwalior & aged 2 years 1 day as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Atulya Medipharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Atulya Medipharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Atulya Medipharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Atulya Medipharma Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Atulya Medipharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Atulya Medipharma Private Limited

Atulya Medipharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in paper and paper products, within the paper industry. It was incorporated on 11 October 2024 (2+ years old) and is registered under CIN U21002MP2024PTC073205.

Atulya Medipharma reported revenue of ₹20.09 Lakh for FY 2025.

Atulya Medipharma has 4 current directors:

Atulya Medipharma reported a net loss of ₹1.49 Lakh (net margin -7.4%) and EBITDA of -₹1.48 Lakh (EBITDA margin -7.4%) for FY 2025, as per its filed financial statements.

The CIN (Corporate Identification Number) of Atulya Medipharma is U21002MP2024PTC073205. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Atulya Medipharma was incorporated on 11 October 2024, making it 2+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Atulya Medipharma by revenue are Masscure Medicines Private Limited, Suvinys Developers Private Limited, Mehta Formulations Private Limited, Unizy Healthcare Private Limited, Sankarajyothi Ayurvedic and Herbals Private Limited and 5 more, all in the Pharma industry (Formulations).

Gaurav Yadav was appointed as Director on 11 Oct 2024. Gautam Yadav was appointed as Director on 11 Oct 2024. Mohan Singh Rajput was appointed as Director on 11 Oct 2024. Atulya Medipharma has 4 board changes on record in total.

The registered office of Atulya Medipharma is at H No 117 Aranya Sch No 78, Sla 1 Sec A Vijay Nagar, Indore, Madhya Pradesh, India – 452010.

Atulya Medipharma has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh.

Atulya Medipharma operates in the paper industry, in the paper and paper products segment.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available